Raymond James Financial
HURA

Raymond James Financial’s TuHURA Biosciences HURA Stock Holding History

Raymond James Financial’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-78
Closed -$174 – 6942
2025
Q2 		$174 Buy
+78
New +$264 ﹤0.01% 6798

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Raymond James Financial's HURA Position: Q3 2025 in Review

Raymond James Financial sold out of TuHURA Biosciences (HURA) in Q3 2025, closing a stake of 78 shares — an estimated $174 sold.

Raymond James Financial first reported a position in HURA in Q2 2025 and held it in 1 quarter. The position peaked at $174 in Q2 2025. 70 funds tracked by Wall St. Rank hold HURA as of Q3 2025.

  • Raymond James Financial reported no remaining TuHURA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 78 TuHURA Biosciences shares in Q3 2025, an estimated $174.
  • Raymond James Financial first reported a position in TuHURA Biosciences in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's TuHURA Biosciences position peaked at $174 in Q2 2025.
  • 70 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.